Loading...

NCOA1–ALK: a novel ALK rearrangement in one lung adenocarcinoma patient responding to crizotinib treatment

The heterogeneity of ALK tyrosine-kinase inhibitor (TKI) responses poses a puzzling question to clinicians. Different variants of ALK rearrangements might be one of the mechanisms explaining this phenomenon. Therefore, identifying specific fusion forms is crucial to clinical practice. This case repo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Cao, Qi, Liu, Zhiguang, Huang, Yanhua, Qi, Chuang, Yin, Xiaowei
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369846/
https://ncbi.nlm.nih.gov/pubmed/30799936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S192367
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!